Header Logo

Connection

Barish Edil to Drug Eruptions

Back to Details
This is a "connection" page, showing publications Barish Edil has written about Drug Eruptions.
Barish Edil
Connection Strength
0.027
Drug Eruptions
  1. Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer. Int J Radiat Oncol Biol Phys. 2013 Jul 15; 86(4):678-85.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.